Hygeia Hospital- Hygeia Diagnostic & Therapeutic Center of Athens
- Address
- Erythrou Stavrou 4, 15124 Athens, Greece
Hygeia Hospital - Diagnostic & Therapeutic Center of Athens
Hygeia Hospital's Diagnostic & Therapeutic Center of Athens is a leading medical research institution conducting advanced clinical trials across multiple therapeutic areas. The center demonstrates particular expertise in cardiovascular medicine and oncology, with focus on innovative treatment strategies for complex metabolic disorders and advanced malignancies.
- Cardiovascular and metabolic disease management, including combination therapies for mixed dyslipidaemia
- Advanced prostate cancer research, focusing on metastatic castration-resistant prostate cancer (mCRPC)
- Novel therapeutic combinations for high-risk patient populations
The center's research portfolio includes comparative effectiveness studies of fixed-dose combination therapies for patients with elevated cardiovascular risk, as well as phase III oncology trials evaluating targeted therapies combined with chemotherapy in patients with advanced genitourinary cancers. Their trials emphasize both efficacy and safety outcomes, with particular attention to improving overall survival and progression-free survival in challenging patient populations who are not achieving therapeutic goals with standard treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Laboratoires S.M.B.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hygeia Hospital- Hygeia Diagnostic & Therapeutic Center of Athens
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Capivasertib Plus Docetaxel in Metastatic Castration-Resistant Prostate Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Study | AstraZeneca AB | Phase III | Not Recruiting | Jul 2022 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capivasertib | 1 | Unknown | 2022-07-21 | 2022-07-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.